Feb 6, 2026
What clinical trials are currently recruiting to test ivermectin in cancer patients and what endpoints do they use?
A single actively registered clinical trial testing has been identified: a Phase I/II study (NCT05318469) combining oral ivermectin with anti‑PD‑1 immune checkpoint therapy for (mTNBC), and its primar...